Catherine “Cathie” Wood, the CEO of ARK Investment Management LLC, has been buying up shares of Nurix Therapeutics Inc (NASDAQ:NRIX) in every trading session since October 10.
Once regarded as a visionary in terms of the next big technology innovations, Wood suffered big losses for her funds after continuing to bet on high-valuation growth stocks.
Recently, however, Wood added more than 840,000 shares of the low-priced NRIX stock to ARK Genomic Revolution ETF (BATS:ARKG).
Institutional Investors Love Nurix Therapeutics Inc
This post appeared first on Profit Confidential.